Home › Funds › Renaissance Technologies › APYX
Renaissance Technologies position in APYX
APYX MEDICAL CORPORATION · Health Care
Latest position (Q2 2026)554.28K sh
Reported value held$2.49M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 483.89K | $6.70M | New |
| Q4 2021 | 483.80K | $6.20M | Hold |
| Q1 2022 | 512.01K | $3.34M | Add |
| Q2 2022 | 541.98K | $3.18M | Add |
| Q3 2022 | 428.10K | $1.92M | Reduce |
| Q4 2022 | 368.19K | $862 | Reduce |
| Q1 2023 | 331.10K | $954 | Reduce |
| Q2 2023 | 285.50K | $1.44K | Reduce |
| Q3 2023 | 404.41K | $1.29K | Add |
| Q4 2023 | 370.50K | $971 | Reduce |
| Q1 2024 | 252.02K | $343 | Reduce |
| Q2 2024 | 216.59K | $290.24K | Reduce |
| Q3 2024 | 203.29K | $252.09K | Reduce |
| Q4 2024 | 206.19K | $325.79K | Add |
| Q1 2025 | 202.00K | $276.73K | Reduce |
| Q1 2025 | 202.00K | $276.73K | Reduce |
| Q2 2025 | 181.40K | $408.14K | Reduce |
| Q2 2025 | 181.40K | $408.14K | Reduce |
| Q3 2025 | 221.70K | $474.43K | Add |
| Q4 2025 | 220.40K | $771.38K | Reduce |
| Q1 2026 | 302.39K | $1.12M | Add |
| Q2 2026 | 554.28K | $2.49M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding APYX
- Royce & Associates 3.27M sh · $14.70M · Q2 2026
- Vanguard Group 1.57M sh · $5.48M · Q4 2025
- BlackRock Inc 560.99K sh · $2.52M · Q2 2026
- Geode Capital Management 400.60K sh · $1.80M · Q2 2026
- Millennium Management 242.66K sh · $1.09M · Q2 2026
- Marshall Wace 236.47K sh · $1.06M · Q2 2026
- Citadel Advisors 168.34K sh · $755.86K · Q2 2026
- Northern Trust Corp 78.57K sh · $352.77K · Q2 2026
- Goldman Sachs Group 44.39K sh · $199.30K · Q2 2026
- Morgan Stanley 41.34K sh · $185.60K · Q2 2026
- Point72 Asset Management 26.35K sh · $118.31K · Q2 2026